EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum ferritin as a predictive biomarker for PEG IFNα-2b efficacy in chronic hepatitis B treatment

Meiya Chen, Chenhao Wang, Miqiang Lin, Shiran Cai

Frontiers in Cellular and Infection Microbiology · 2025

DOI: 10.3389/fcimb.2025.1603286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Meiya Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Graduate School of Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Interferon-alpha, Polyethylene Glycols, Ferritins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic hepatitis B (CHB) caused by HBV infection leads to persistent liver inflammation. PEG IFNα-2b shows higher functional cure rates than oral antivirals, but identifying optimal candidates remains challenging. This study evaluates serum ferritin as a predictive biomarker for PEG IFNα-2b efficacy.

Methods

Serum ferritin, HBsAg and transaminase were monitored in CHB patients treated with PEG IFN α-2b at baseline (0w), 12w and 24w. Patients were divided into the effective group (HBsAg reduction ≥1 log10 IU/mL or clearance) and the ineffective group (HBsAg reduction <1 log10 IU/mL) at 24 weeks. Similarly, for the results at 48 weeks, the patients were divided into the clearance group (achieving HBsAg clearance) and the non-clearance group (not achieving HBsAg clearance). To analyze the correlation between serum ferritin and the decrease of HBsAg, a multivariate logistic regression model was constructed. Potential confounding factors such as age, gender, HBeAg and HBV DNA status, ALT, AST, and iron metabolism indicators (FE, TIBC, TS) were included to evaluate the independent predictive effect of ferritin levels on the therapeutic effectiveness, calculate the corrected OR value and 95% CI. The predictive effect was evaluated by the ROC curve.

Results

Among patients with chronic hepatitis B (CHB) who completed the PEG IFNα-2b course of treatment, the serum ferritin levels of all patients showed an increasing trend at baseline and during the treatment process, and the serum ferritin level in the effective treatment group (HBsAg reduction ≥1 log10 IU/mL or clearance) was significantly higher than that in the ineffective treatment group. It was confirmed by Spearman’s rank correlation analysis that the serum ferritin level was positively correlated with the decrease in HBsAg. Further analysis through the multivariate logistic regression model revealed that serum ferritin remained an independent predictor of the antiviral efficacy of PEG IFNα-2b. ROC curve analysis indicated that serum ferritin had a high predictive value for the antiviral efficacy of PEG IFNα-2b.

Conclusion

The level of serum ferritin is closely related to the anti-hepatitis B virus efficacy of PEG IFNα-2b. It has great potential as a reliable and economical biomarker to guide treatment and optimize treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicInterferon-alphaPolyethylene GlycolsFerritinsAntiviral AgentsBiomarkersHumansMaleFemaleRecombinant ProteinsAdultMiddle AgedTreatment OutcomeHepatitis B Surface AntigensROC CurveInterferon alpha-2Hepatitis B virusAlanine TransaminaseYoung AdultDNA, Viral

Stichwörter der Autor:innen

ALTHBsAgPEG IFN-α2bchronic hepatitis Bserum ferritin

Substanzen

Interferon-alphaPolyethylene GlycolsRecombinant ProteinsFerritinsAntiviral AgentsBiomarkerspeginterferon alfa-2bHepatitis B Surface AntigensInterferon alpha-2Alanine Transaminase

Autor:innen und Institutionen

  • The Graduate School of Fujian Medical University, Fuzhou, China.
  • Department of Gastroenterology, The National Key Clinical Specialty, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.
  • Department of Gastroenterology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.

Zitieren

APA

Chen, M., Wang, C., Lin, M., & Cai, S. (2025). Serum ferritin as a predictive biomarker for PEG IFNα-2b efficacy in chronic hepatitis B treatment. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1603286

Vancouver

Chen M, Wang C, Lin M, Cai S. Serum ferritin as a predictive biomarker for PEG IFNα-2b efficacy in chronic hepatitis B treatment. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1603286

BibTeX
@article{Chen2025,
  author = {Chen, Meiya and Wang, Chenhao and Lin, Miqiang and Cai, Shiran},
  title = {Serum ferritin as a predictive biomarker for PEG IFNα-2b efficacy in chronic hepatitis B treatment},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2025},
  doi = {10.3389/fcimb.2025.1603286}
}
Kostenlos starten →